nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—CA3—obesity	0.277	0.765	CbGaD
Imatinib—SLC22A1—obesity	0.0651	0.18	CbGaD
Imatinib—SLC47A1—Cimetidine—obesity	0.0541	0.145	CbGbCtD
Imatinib—CA6—Topiramate—obesity	0.0281	0.0756	CbGbCtD
Imatinib—ORM1—Bupropion—obesity	0.0276	0.0741	CbGbCtD
Imatinib—CA7—Topiramate—obesity	0.0245	0.0659	CbGbCtD
Imatinib—CA9—Topiramate—obesity	0.021	0.0565	CbGbCtD
Imatinib—CA12—Topiramate—obesity	0.021	0.0565	CbGbCtD
Imatinib—ALB—obesity	0.0198	0.0549	CbGaD
Imatinib—CA1—Topiramate—obesity	0.0197	0.0529	CbGbCtD
Imatinib—CA2—Topiramate—obesity	0.017	0.0457	CbGbCtD
Imatinib—SLC22A2—Cimetidine—obesity	0.0167	0.045	CbGbCtD
Imatinib—SLC22A1—Cimetidine—obesity	0.0145	0.0391	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Cimetidine—obesity	0.00913	0.0245	CbGbCtD
Imatinib—CYP3A7—Cimetidine—obesity	0.00913	0.0245	CbGbCtD
Imatinib—CYP1A2—Phentermine—obesity	0.00817	0.0219	CbGbCtD
Imatinib—CYP1A2—Phenylpropanolamine—obesity	0.00779	0.0209	CbGbCtD
Imatinib—CYP2C9—Phentermine—obesity	0.00736	0.0198	CbGbCtD
Imatinib—CYP1A2—Bupropion—obesity	0.00694	0.0186	CbGbCtD
Imatinib—CYP3A5—Cimetidine—obesity	0.00685	0.0184	CbGbCtD
Imatinib—CYP2D6—Phentermine—obesity	0.00673	0.0181	CbGbCtD
Imatinib—CYP2C9—Bupropion—obesity	0.00626	0.0168	CbGbCtD
Imatinib—CYP2D6—Bupropion—obesity	0.00572	0.0154	CbGbCtD
Imatinib—CYP3A4—Sibutramine—obesity	0.00565	0.0152	CbGbCtD
Imatinib—CYP2C19—Cimetidine—obesity	0.00552	0.0148	CbGbCtD
Imatinib—CYP2D6—Methamphetamine—obesity	0.00538	0.0144	CbGbCtD
Imatinib—CYP1A2—Cimetidine—obesity	0.0051	0.0137	CbGbCtD
Imatinib—CYP2C9—Cimetidine—obesity	0.00459	0.0123	CbGbCtD
Imatinib—ABCB1—Cimetidine—obesity	0.00446	0.012	CbGbCtD
Imatinib—CYP3A4—Benzphetamine—obesity	0.00428	0.0115	CbGbCtD
Imatinib—CYP2D6—Cimetidine—obesity	0.0042	0.0113	CbGbCtD
Imatinib—CYP3A4—Bupropion—obesity	0.00364	0.00977	CbGbCtD
Imatinib—CYP2C19—Topiramate—obesity	0.00362	0.00971	CbGbCtD
Imatinib—CYP3A4—Orlistat—obesity	0.00297	0.00796	CbGbCtD
Imatinib—CYP3A4—Cimetidine—obesity	0.00267	0.00717	CbGbCtD
Imatinib—ORM1—bile—obesity	0.00183	0.0354	CbGeAlD
Imatinib—CYP3A4—Topiramate—obesity	0.00175	0.00469	CbGbCtD
Imatinib—Nilotinib—CA3—obesity	0.0014	0.578	CrCbGaD
Imatinib—ABCA3—islet of Langerhans—obesity	0.00109	0.0211	CbGeAlD
Imatinib—ABCA3—respiratory system—obesity	0.00103	0.0199	CbGeAlD
Imatinib—Nilotinib—MAPK8—obesity	0.00102	0.422	CrCbGaD
Imatinib—DDR1—islet of Langerhans—obesity	0.00101	0.0194	CbGeAlD
Imatinib—CA9—gall bladder—obesity	0.000866	0.0167	CbGeAlD
Imatinib—DDR1—adrenal cortex—obesity	0.000797	0.0154	CbGeAlD
Imatinib—NQO2—hindbrain—obesity	0.000705	0.0136	CbGeAlD
Imatinib—ABCA3—pituitary gland—obesity	0.000698	0.0135	CbGeAlD
Imatinib—ABCA3—adipose tissue—obesity	0.000695	0.0134	CbGeAlD
Imatinib—PDGFRA—gall bladder—obesity	0.000694	0.0134	CbGeAlD
Imatinib—DDR1—pituitary gland—obesity	0.000644	0.0125	CbGeAlD
Imatinib—DDR1—adipose tissue—obesity	0.000642	0.0124	CbGeAlD
Imatinib—ABCA3—adrenal gland—obesity	0.000624	0.0121	CbGeAlD
Imatinib—PIP4K2C—islet of Langerhans—obesity	0.000621	0.012	CbGeAlD
Imatinib—DDR1—adrenal gland—obesity	0.000576	0.0111	CbGeAlD
Imatinib—CA9—islet of Langerhans—obesity	0.000568	0.011	CbGeAlD
Imatinib—SLC47A1—hindbrain—obesity	0.000566	0.0109	CbGeAlD
Imatinib—KIT—hindbrain—obesity	0.000562	0.0109	CbGeAlD
Imatinib—CA3—respiratory system—obesity	0.00056	0.0108	CbGeAlD
Imatinib—KIT—gall bladder—obesity	0.000555	0.0107	CbGeAlD
Imatinib—HIPK4—endocrine gland—obesity	0.000547	0.0106	CbGeAlD
Imatinib—PDGFRB—gall bladder—obesity	0.000542	0.0105	CbGeAlD
Imatinib—ORM1—gall bladder—obesity	0.000508	0.00982	CbGeAlD
Imatinib—PIP4K2C—adrenal cortex—obesity	0.000492	0.00951	CbGeAlD
Imatinib—ABL1—hindbrain—obesity	0.00049	0.00946	CbGeAlD
Imatinib—NQO2—islet of Langerhans—obesity	0.000456	0.00881	CbGeAlD
Imatinib—DDR1—liver—obesity	0.00045	0.0087	CbGeAlD
Imatinib—ALB—gall bladder—obesity	0.000446	0.00861	CbGeAlD
Imatinib—PDGFRA—respiratory system—obesity	0.00043	0.0083	CbGeAlD
Imatinib—CA3—cardiovascular system—obesity	0.000429	0.00829	CbGeAlD
Imatinib—ABL2—pituitary gland—obesity	0.00042	0.00812	CbGeAlD
Imatinib—ABL2—adipose tissue—obesity	0.000419	0.00809	CbGeAlD
Imatinib—PIP4K2C—pituitary gland—obesity	0.000398	0.00769	CbGeAlD
Imatinib—CA12—respiratory system—obesity	0.000397	0.00766	CbGeAlD
Imatinib—PIP4K2C—adipose tissue—obesity	0.000396	0.00765	CbGeAlD
Imatinib—CA7—digestive system—obesity	0.000388	0.0075	CbGeAlD
Imatinib—CA3—pituitary gland—obesity	0.00038	0.00734	CbGeAlD
Imatinib—CSF1R—respiratory system—obesity	0.000378	0.00731	CbGeAlD
Imatinib—CA3—adipose tissue—obesity	0.000378	0.00731	CbGeAlD
Imatinib—ABL2—adrenal gland—obesity	0.000376	0.00726	CbGeAlD
Imatinib—NQO2—adrenal cortex—obesity	0.000362	0.00699	CbGeAlD
Imatinib—PIP4K2C—adrenal gland—obesity	0.000355	0.00687	CbGeAlD
Imatinib—PDGFRB—islet of Langerhans—obesity	0.000355	0.00687	CbGeAlD
Imatinib—LCK—adipose tissue—obesity	0.000352	0.00679	CbGeAlD
Imatinib—KIT—respiratory system—obesity	0.000343	0.00664	CbGeAlD
Imatinib—CA9—digestive system—obesity	0.000341	0.00659	CbGeAlD
Imatinib—PDGFRB—respiratory system—obesity	0.000335	0.00648	CbGeAlD
Imatinib—CA2—hindbrain—obesity	0.000333	0.00644	CbGeAlD
Imatinib—PDGFRA—cardiovascular system—obesity	0.000329	0.00636	CbGeAlD
Imatinib—CA2—gall bladder—obesity	0.000329	0.00636	CbGeAlD
Imatinib—CSF1R—adrenal cortex—obesity	0.000317	0.00613	CbGeAlD
Imatinib—ABL1—islet of Langerhans—obesity	0.000317	0.00612	CbGeAlD
Imatinib—LCK—adrenal gland—obesity	0.000315	0.00609	CbGeAlD
Imatinib—CA1—respiratory system—obesity	0.000314	0.00607	CbGeAlD
Imatinib—PIP4K2C—endocrine gland—obesity	0.000308	0.00595	CbGeAlD
Imatinib—CA14—adrenal gland—obesity	0.000308	0.00595	CbGeAlD
Imatinib—ABL1—respiratory system—obesity	0.000299	0.00578	CbGeAlD
Imatinib—CA3—endocrine gland—obesity	0.000294	0.00569	CbGeAlD
Imatinib—ABL2—liver—obesity	0.000294	0.00567	CbGeAlD
Imatinib—NQO2—pituitary gland—obesity	0.000292	0.00564	CbGeAlD
Imatinib—NQO2—adipose tissue—obesity	0.000291	0.00562	CbGeAlD
Imatinib—PDGFRA—adipose tissue—obesity	0.00029	0.00561	CbGeAlD
Imatinib—SLC47A1—adrenal cortex—obesity	0.00029	0.0056	CbGeAlD
Imatinib—CSF1R—cardiovascular system—obesity	0.00029	0.0056	CbGeAlD
Imatinib—CA9—endocrine gland—obesity	0.000282	0.00544	CbGeAlD
Imatinib—PDGFRB—adrenal cortex—obesity	0.000282	0.00544	CbGeAlD
Imatinib—PIP4K2C—liver—obesity	0.000278	0.00537	CbGeAlD
Imatinib—PDGFRA—digestive system—obesity	0.000273	0.00528	CbGeAlD
Imatinib—CA3—liver—obesity	0.000265	0.00513	CbGeAlD
Imatinib—KIT—cardiovascular system—obesity	0.000263	0.00508	CbGeAlD
Imatinib—CYP3A7—endocrine gland—obesity	0.000261	0.00505	CbGeAlD
Imatinib—NQO2—adrenal gland—obesity	0.000261	0.00504	CbGeAlD
Imatinib—PDGFRA—adrenal gland—obesity	0.00026	0.00503	CbGeAlD
Imatinib—SLC22A2—digestive system—obesity	0.000259	0.00501	CbGeAlD
Imatinib—PDGFRB—cardiovascular system—obesity	0.000257	0.00497	CbGeAlD
Imatinib—CSF1R—pituitary gland—obesity	0.000257	0.00496	CbGeAlD
Imatinib—CSF1R—adipose tissue—obesity	0.000255	0.00494	CbGeAlD
Imatinib—CA12—digestive system—obesity	0.000252	0.00487	CbGeAlD
Imatinib—ABL1—adrenal cortex—obesity	0.000251	0.00485	CbGeAlD
Imatinib—LCK—liver—obesity	0.000247	0.00477	CbGeAlD
Imatinib—CA14—liver—obesity	0.000241	0.00465	CbGeAlD
Imatinib—CA1—cardiovascular system—obesity	0.000241	0.00465	CbGeAlD
Imatinib—CSF1R—digestive system—obesity	0.000241	0.00465	CbGeAlD
Imatinib—CYP3A7—liver—obesity	0.000236	0.00455	CbGeAlD
Imatinib—SLC47A1—pituitary gland—obesity	0.000234	0.00453	CbGeAlD
Imatinib—SLC47A1—adipose tissue—obesity	0.000233	0.00451	CbGeAlD
Imatinib—KIT—pituitary gland—obesity	0.000233	0.0045	CbGeAlD
Imatinib—KIT—adipose tissue—obesity	0.000232	0.00448	CbGeAlD
Imatinib—CSF1R—adrenal gland—obesity	0.000229	0.00443	CbGeAlD
Imatinib—ABL1—cardiovascular system—obesity	0.000229	0.00443	CbGeAlD
Imatinib—PDGFRB—pituitary gland—obesity	0.000228	0.0044	CbGeAlD
Imatinib—PDGFRB—adipose tissue—obesity	0.000227	0.00438	CbGeAlD
Imatinib—NQO2—endocrine gland—obesity	0.000226	0.00437	CbGeAlD
Imatinib—PDGFRA—endocrine gland—obesity	0.000226	0.00436	CbGeAlD
Imatinib—SLC47A1—digestive system—obesity	0.00022	0.00424	CbGeAlD
Imatinib—KIT—digestive system—obesity	0.000218	0.00422	CbGeAlD
Imatinib—CA2—islet of Langerhans—obesity	0.000216	0.00417	CbGeAlD
Imatinib—PDGFRB—digestive system—obesity	0.000213	0.00412	CbGeAlD
Imatinib—CA1—adipose tissue—obesity	0.000212	0.0041	CbGeAlD
Imatinib—CYP2D6—hindbrain—obesity	0.000212	0.00409	CbGeAlD
Imatinib—SLC47A1—adrenal gland—obesity	0.000209	0.00404	CbGeAlD
Imatinib—CA12—endocrine gland—obesity	0.000208	0.00403	CbGeAlD
Imatinib—KIT—adrenal gland—obesity	0.000208	0.00402	CbGeAlD
Imatinib—NQO2—liver—obesity	0.000204	0.00394	CbGeAlD
Imatinib—CA2—respiratory system—obesity	0.000204	0.00393	CbGeAlD
Imatinib—PDGFRA—liver—obesity	0.000204	0.00393	CbGeAlD
Imatinib—PDGFRB—adrenal gland—obesity	0.000203	0.00393	CbGeAlD
Imatinib—ABL1—pituitary gland—obesity	0.000203	0.00392	CbGeAlD
Imatinib—ABL1—adipose tissue—obesity	0.000202	0.0039	CbGeAlD
Imatinib—CYP3A7-CYP3A51P—liver—obesity	0.0002	0.00387	CbGeAlD
Imatinib—CA1—digestive system—obesity	0.0002	0.00386	CbGeAlD
Imatinib—CSF1R—endocrine gland—obesity	0.000199	0.00384	CbGeAlD
Imatinib—SLC22A1—adipose tissue—obesity	0.000195	0.00376	CbGeAlD
Imatinib—ABL1—digestive system—obesity	0.00019	0.00367	CbGeAlD
Imatinib—CYP3A5—islet of Langerhans—obesity	0.000185	0.00358	CbGeAlD
Imatinib—SLC47A1—endocrine gland—obesity	0.000181	0.00351	CbGeAlD
Imatinib—CYP1A2—respiratory system—obesity	0.000181	0.00351	CbGeAlD
Imatinib—ABL1—adrenal gland—obesity	0.000181	0.0035	CbGeAlD
Imatinib—KIT—endocrine gland—obesity	0.00018	0.00349	CbGeAlD
Imatinib—CSF1R—liver—obesity	0.000179	0.00346	CbGeAlD
Imatinib—PDGFRB—endocrine gland—obesity	0.000176	0.00341	CbGeAlD
Imatinib—CYP3A5—respiratory system—obesity	0.000175	0.00338	CbGeAlD
Imatinib—CA2—adrenal cortex—obesity	0.000171	0.0033	CbGeAlD
Imatinib—ALB—adrenal gland—obesity	0.000167	0.00323	CbGeAlD
Imatinib—ORM1—endocrine gland—obesity	0.000165	0.00319	CbGeAlD
Imatinib—CA1—endocrine gland—obesity	0.000165	0.00319	CbGeAlD
Imatinib—SLC47A1—liver—obesity	0.000164	0.00316	CbGeAlD
Imatinib—KIT—liver—obesity	0.000163	0.00314	CbGeAlD
Imatinib—PDGFRB—liver—obesity	0.000159	0.00307	CbGeAlD
Imatinib—ABCG2—adrenal cortex—obesity	0.000158	0.00306	CbGeAlD
Imatinib—PTGS1—respiratory system—obesity	0.000157	0.00304	CbGeAlD
Imatinib—ABL1—endocrine gland—obesity	0.000157	0.00304	CbGeAlD
Imatinib—CA2—cardiovascular system—obesity	0.000156	0.00301	CbGeAlD
Imatinib—SLC22A1—endocrine gland—obesity	0.000151	0.00293	CbGeAlD
Imatinib—ORM1—liver—obesity	0.000149	0.00288	CbGeAlD
Imatinib—CA1—liver—obesity	0.000149	0.00288	CbGeAlD
Imatinib—ABL1—liver—obesity	0.000142	0.00274	CbGeAlD
Imatinib—CYP2C19—digestive system—obesity	0.000141	0.00273	CbGeAlD
Imatinib—CA2—pituitary gland—obesity	0.000138	0.00267	CbGeAlD
Imatinib—CA2—adipose tissue—obesity	0.000138	0.00266	CbGeAlD
Imatinib—SLC22A1—liver—obesity	0.000137	0.00264	CbGeAlD
Imatinib—CYP2C9—cardiovascular system—obesity	0.000132	0.00255	CbGeAlD
Imatinib—ALB—liver—obesity	0.000131	0.00253	CbGeAlD
Imatinib—CA2—digestive system—obesity	0.000129	0.0025	CbGeAlD
Imatinib—ABCG2—pituitary gland—obesity	0.000128	0.00247	CbGeAlD
Imatinib—ABCG2—adipose tissue—obesity	0.000127	0.00246	CbGeAlD
Imatinib—CA2—adrenal gland—obesity	0.000123	0.00238	CbGeAlD
Imatinib—PTGS1—cardiovascular system—obesity	0.00012	0.00233	CbGeAlD
Imatinib—CYP3A5—adipose tissue—obesity	0.000118	0.00228	CbGeAlD
Imatinib—CYP2C19—endocrine gland—obesity	0.000117	0.00226	CbGeAlD
Imatinib—CYP1A2—digestive system—obesity	0.000115	0.00223	CbGeAlD
Imatinib—ABCG2—adrenal gland—obesity	0.000114	0.00221	CbGeAlD
Imatinib—CYP3A5—digestive system—obesity	0.000111	0.00215	CbGeAlD
Imatinib—CYP2C9—digestive system—obesity	0.00011	0.00212	CbGeAlD
Imatinib—CA2—endocrine gland—obesity	0.000107	0.00207	CbGeAlD
Imatinib—PTGS1—pituitary gland—obesity	0.000107	0.00206	CbGeAlD
Imatinib—PTGS1—adipose tissue—obesity	0.000106	0.00205	CbGeAlD
Imatinib—CYP2C19—liver—obesity	0.000105	0.00203	CbGeAlD
Imatinib—PTGS1—digestive system—obesity	0.0001	0.00193	CbGeAlD
Imatinib—ABCB1—islet of Langerhans—obesity	9.85e-05	0.0019	CbGeAlD
Imatinib—CA2—liver—obesity	9.64e-05	0.00186	CbGeAlD
Imatinib—CYP1A2—endocrine gland—obesity	9.53e-05	0.00184	CbGeAlD
Imatinib—PTGS1—adrenal gland—obesity	9.53e-05	0.00184	CbGeAlD
Imatinib—ABCB1—respiratory system—obesity	9.3e-05	0.0018	CbGeAlD
Imatinib—CYP3A5—endocrine gland—obesity	9.2e-05	0.00178	CbGeAlD
Imatinib—CYP2C9—endocrine gland—obesity	9.05e-05	0.00175	CbGeAlD
Imatinib—ABCG2—liver—obesity	8.93e-05	0.00173	CbGeAlD
Imatinib—CYP1A2—liver—obesity	8.6e-05	0.00166	CbGeAlD
Imatinib—CYP3A4—digestive system—obesity	8.35e-05	0.00161	CbGeAlD
Imatinib—CYP3A5—liver—obesity	8.29e-05	0.0016	CbGeAlD
Imatinib—PTGS1—endocrine gland—obesity	8.26e-05	0.0016	CbGeAlD
Imatinib—CYP2D6—digestive system—obesity	8.22e-05	0.00159	CbGeAlD
Imatinib—CYP2C9—liver—obesity	8.16e-05	0.00158	CbGeAlD
Imatinib—ABCB1—adrenal cortex—obesity	7.8e-05	0.00151	CbGeAlD
Imatinib—Anaphylactic shock—Orlistat—obesity	7.12e-05	0.000629	CcSEcCtD
Imatinib—Oedema—Orlistat—obesity	7.12e-05	0.000629	CcSEcCtD
Imatinib—ABCB1—cardiovascular system—obesity	7.12e-05	0.00138	CbGeAlD
Imatinib—Back pain—Bupropion—obesity	7.12e-05	0.000629	CcSEcCtD
Imatinib—Abdominal pain upper—Topiramate—obesity	7.11e-05	0.000628	CcSEcCtD
Imatinib—Discomfort—Sibutramine—obesity	7.1e-05	0.000627	CcSEcCtD
Imatinib—Hypokalaemia—Topiramate—obesity	7.09e-05	0.000626	CcSEcCtD
Imatinib—Muscle spasms—Bupropion—obesity	7.08e-05	0.000625	CcSEcCtD
Imatinib—Infection—Orlistat—obesity	7.08e-05	0.000625	CcSEcCtD
Imatinib—Breast disorder—Topiramate—obesity	7.04e-05	0.000622	CcSEcCtD
Imatinib—Dry mouth—Sibutramine—obesity	7.03e-05	0.000621	CcSEcCtD
Imatinib—Aspartate aminotransferase increased—Topiramate—obesity	7.01e-05	0.00062	CcSEcCtD
Imatinib—Toxic epidermal necrolysis—Topiramate—obesity	7.01e-05	0.00062	CcSEcCtD
Imatinib—Nervous system disorder—Orlistat—obesity	6.98e-05	0.000617	CcSEcCtD
Imatinib—Nasopharyngitis—Topiramate—obesity	6.96e-05	0.000615	CcSEcCtD
Imatinib—Confusional state—Sibutramine—obesity	6.95e-05	0.000614	CcSEcCtD
Imatinib—Vision blurred—Bupropion—obesity	6.94e-05	0.000613	CcSEcCtD
Imatinib—Skin disorder—Orlistat—obesity	6.92e-05	0.000611	CcSEcCtD
Imatinib—CYP3A4—endocrine gland—obesity	6.9e-05	0.00133	CbGeAlD
Imatinib—Tremor—Bupropion—obesity	6.9e-05	0.000609	CcSEcCtD
Imatinib—Gastritis—Topiramate—obesity	6.89e-05	0.000609	CcSEcCtD
Imatinib—Anaphylactic shock—Sibutramine—obesity	6.89e-05	0.000609	CcSEcCtD
Imatinib—Oedema—Sibutramine—obesity	6.89e-05	0.000609	CcSEcCtD
Imatinib—Hyperhidrosis—Orlistat—obesity	6.88e-05	0.000608	CcSEcCtD
Imatinib—Alanine aminotransferase increased—Topiramate—obesity	6.87e-05	0.000607	CcSEcCtD
Imatinib—Muscular weakness—Topiramate—obesity	6.87e-05	0.000607	CcSEcCtD
Imatinib—Infection—Sibutramine—obesity	6.85e-05	0.000605	CcSEcCtD
Imatinib—Ill-defined disorder—Bupropion—obesity	6.83e-05	0.000603	CcSEcCtD
Imatinib—Anaemia—Bupropion—obesity	6.8e-05	0.000601	CcSEcCtD
Imatinib—CYP2D6—endocrine gland—obesity	6.79e-05	0.00131	CbGeAlD
Imatinib—Shock—Sibutramine—obesity	6.78e-05	0.000599	CcSEcCtD
Imatinib—Abdominal distension—Topiramate—obesity	6.78e-05	0.000599	CcSEcCtD
Imatinib—Thrombocytopenia—Sibutramine—obesity	6.75e-05	0.000596	CcSEcCtD
Imatinib—Dysphagia—Topiramate—obesity	6.73e-05	0.000595	CcSEcCtD
Imatinib—Angioedema—Bupropion—obesity	6.73e-05	0.000594	CcSEcCtD
Imatinib—Tachycardia—Sibutramine—obesity	6.73e-05	0.000594	CcSEcCtD
Imatinib—Skin disorder—Sibutramine—obesity	6.69e-05	0.000591	CcSEcCtD
Imatinib—Eosinophilia—Topiramate—obesity	6.67e-05	0.000589	CcSEcCtD
Imatinib—Hyperhidrosis—Sibutramine—obesity	6.66e-05	0.000589	CcSEcCtD
Imatinib—Malaise—Bupropion—obesity	6.64e-05	0.000586	CcSEcCtD
Imatinib—Vertigo—Bupropion—obesity	6.61e-05	0.000584	CcSEcCtD
Imatinib—Syncope—Bupropion—obesity	6.6e-05	0.000583	CcSEcCtD
Imatinib—Pancreatitis—Topiramate—obesity	6.6e-05	0.000583	CcSEcCtD
Imatinib—Leukopenia—Bupropion—obesity	6.59e-05	0.000582	CcSEcCtD
Imatinib—Anorexia—Sibutramine—obesity	6.57e-05	0.00058	CcSEcCtD
Imatinib—Angina pectoris—Topiramate—obesity	6.56e-05	0.000579	CcSEcCtD
Imatinib—Sweating increased—Topiramate—obesity	6.56e-05	0.000579	CcSEcCtD
Imatinib—Palpitations—Bupropion—obesity	6.51e-05	0.000575	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Orlistat—obesity	6.49e-05	0.000573	CcSEcCtD
Imatinib—Loss of consciousness—Bupropion—obesity	6.47e-05	0.000572	CcSEcCtD
Imatinib—Insomnia—Orlistat—obesity	6.44e-05	0.000569	CcSEcCtD
Imatinib—Hypotension—Sibutramine—obesity	6.44e-05	0.000569	CcSEcCtD
Imatinib—Cough—Bupropion—obesity	6.42e-05	0.000567	CcSEcCtD
Imatinib—Paraesthesia—Orlistat—obesity	6.39e-05	0.000565	CcSEcCtD
Imatinib—Pancytopenia—Topiramate—obesity	6.39e-05	0.000565	CcSEcCtD
Imatinib—Convulsion—Bupropion—obesity	6.38e-05	0.000563	CcSEcCtD
Imatinib—Hypertension—Bupropion—obesity	6.36e-05	0.000561	CcSEcCtD
Imatinib—ABCB1—pituitary gland—obesity	6.31e-05	0.00122	CbGeAlD
Imatinib—Neutropenia—Topiramate—obesity	6.29e-05	0.000556	CcSEcCtD
Imatinib—ABCB1—adipose tissue—obesity	6.28e-05	0.00121	CbGeAlD
Imatinib—Musculoskeletal discomfort—Sibutramine—obesity	6.28e-05	0.000555	CcSEcCtD
Imatinib—Dyspepsia—Orlistat—obesity	6.27e-05	0.000554	CcSEcCtD
Imatinib—Arthralgia—Bupropion—obesity	6.27e-05	0.000554	CcSEcCtD
Imatinib—Myalgia—Bupropion—obesity	6.27e-05	0.000554	CcSEcCtD
Imatinib—Chest pain—Bupropion—obesity	6.27e-05	0.000554	CcSEcCtD
Imatinib—Upper respiratory tract infection—Topiramate—obesity	6.26e-05	0.000553	CcSEcCtD
Imatinib—Anxiety—Bupropion—obesity	6.25e-05	0.000552	CcSEcCtD
Imatinib—Insomnia—Sibutramine—obesity	6.23e-05	0.000551	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	6.22e-05	0.00055	CcSEcCtD
Imatinib—CYP3A4—liver—obesity	6.22e-05	0.0012	CbGeAlD
Imatinib—Pollakiuria—Topiramate—obesity	6.22e-05	0.000549	CcSEcCtD
Imatinib—Erectile dysfunction—Topiramate—obesity	6.2e-05	0.000548	CcSEcCtD
Imatinib—Discomfort—Bupropion—obesity	6.19e-05	0.000547	CcSEcCtD
Imatinib—Decreased appetite—Orlistat—obesity	6.19e-05	0.000547	CcSEcCtD
Imatinib—Paraesthesia—Sibutramine—obesity	6.19e-05	0.000547	CcSEcCtD
Imatinib—Gastrointestinal disorder—Orlistat—obesity	6.15e-05	0.000543	CcSEcCtD
Imatinib—Dyspnoea—Sibutramine—obesity	6.14e-05	0.000543	CcSEcCtD
Imatinib—Photosensitivity reaction—Topiramate—obesity	6.14e-05	0.000543	CcSEcCtD
Imatinib—Fatigue—Orlistat—obesity	6.14e-05	0.000542	CcSEcCtD
Imatinib—Dry mouth—Bupropion—obesity	6.13e-05	0.000541	CcSEcCtD
Imatinib—Somnolence—Sibutramine—obesity	6.13e-05	0.000541	CcSEcCtD
Imatinib—Weight increased—Topiramate—obesity	6.13e-05	0.000541	CcSEcCtD
Imatinib—CYP2D6—liver—obesity	6.12e-05	0.00118	CbGeAlD
Imatinib—Weight decreased—Topiramate—obesity	6.09e-05	0.000538	CcSEcCtD
Imatinib—Pain—Orlistat—obesity	6.09e-05	0.000538	CcSEcCtD
Imatinib—Hyperglycaemia—Topiramate—obesity	6.07e-05	0.000536	CcSEcCtD
Imatinib—Dyspepsia—Sibutramine—obesity	6.07e-05	0.000536	CcSEcCtD
Imatinib—Confusional state—Bupropion—obesity	6.06e-05	0.000535	CcSEcCtD
Imatinib—Pneumonia—Topiramate—obesity	6.04e-05	0.000533	CcSEcCtD
Imatinib—Anaphylactic shock—Bupropion—obesity	6.01e-05	0.000531	CcSEcCtD
Imatinib—Oedema—Bupropion—obesity	6.01e-05	0.000531	CcSEcCtD
Imatinib—Infestation NOS—Topiramate—obesity	6e-05	0.00053	CcSEcCtD
Imatinib—Infestation—Topiramate—obesity	6e-05	0.00053	CcSEcCtD
Imatinib—Decreased appetite—Sibutramine—obesity	5.99e-05	0.000529	CcSEcCtD
Imatinib—Depression—Topiramate—obesity	5.99e-05	0.000529	CcSEcCtD
Imatinib—Infection—Bupropion—obesity	5.97e-05	0.000527	CcSEcCtD
Imatinib—Stevens-Johnson syndrome—Topiramate—obesity	5.95e-05	0.000526	CcSEcCtD
Imatinib—Gastrointestinal disorder—Sibutramine—obesity	5.95e-05	0.000526	CcSEcCtD
Imatinib—ABCB1—digestive system—obesity	5.91e-05	0.00114	CbGeAlD
Imatinib—Shock—Bupropion—obesity	5.91e-05	0.000522	CcSEcCtD
Imatinib—Renal failure—Topiramate—obesity	5.9e-05	0.000521	CcSEcCtD
Imatinib—Pain—Sibutramine—obesity	5.89e-05	0.000521	CcSEcCtD
Imatinib—Constipation—Sibutramine—obesity	5.89e-05	0.000521	CcSEcCtD
Imatinib—Nervous system disorder—Bupropion—obesity	5.89e-05	0.00052	CcSEcCtD
Imatinib—Neuropathy peripheral—Topiramate—obesity	5.88e-05	0.00052	CcSEcCtD
Imatinib—Thrombocytopenia—Bupropion—obesity	5.88e-05	0.00052	CcSEcCtD
Imatinib—Feeling abnormal—Orlistat—obesity	5.87e-05	0.000518	CcSEcCtD
Imatinib—Tachycardia—Bupropion—obesity	5.86e-05	0.000518	CcSEcCtD
Imatinib—Stomatitis—Topiramate—obesity	5.85e-05	0.000517	CcSEcCtD
Imatinib—Skin disorder—Bupropion—obesity	5.84e-05	0.000516	CcSEcCtD
Imatinib—Conjunctivitis—Topiramate—obesity	5.83e-05	0.000515	CcSEcCtD
Imatinib—Urinary tract infection—Topiramate—obesity	5.83e-05	0.000515	CcSEcCtD
Imatinib—Gastrointestinal pain—Orlistat—obesity	5.82e-05	0.000514	CcSEcCtD
Imatinib—Hyperhidrosis—Bupropion—obesity	5.81e-05	0.000513	CcSEcCtD
Imatinib—Anorexia—Bupropion—obesity	5.73e-05	0.000506	CcSEcCtD
Imatinib—Haematuria—Topiramate—obesity	5.72e-05	0.000505	CcSEcCtD
Imatinib—Feeling abnormal—Sibutramine—obesity	5.68e-05	0.000502	CcSEcCtD
Imatinib—Epistaxis—Topiramate—obesity	5.66e-05	0.0005	CcSEcCtD
Imatinib—Urticaria—Orlistat—obesity	5.66e-05	0.0005	CcSEcCtD
Imatinib—Gastrointestinal pain—Sibutramine—obesity	5.64e-05	0.000498	CcSEcCtD
Imatinib—ABCB1—adrenal gland—obesity	5.63e-05	0.00109	CbGeAlD
Imatinib—Sinusitis—Topiramate—obesity	5.63e-05	0.000497	CcSEcCtD
Imatinib—Abdominal pain—Orlistat—obesity	5.63e-05	0.000497	CcSEcCtD
Imatinib—Body temperature increased—Orlistat—obesity	5.63e-05	0.000497	CcSEcCtD
Imatinib—Hypotension—Bupropion—obesity	5.61e-05	0.000496	CcSEcCtD
Imatinib—Agranulocytosis—Topiramate—obesity	5.6e-05	0.000495	CcSEcCtD
Imatinib—Urticaria—Sibutramine—obesity	5.48e-05	0.000484	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Bupropion—obesity	5.47e-05	0.000484	CcSEcCtD
Imatinib—Body temperature increased—Sibutramine—obesity	5.45e-05	0.000481	CcSEcCtD
Imatinib—Abdominal pain—Sibutramine—obesity	5.45e-05	0.000481	CcSEcCtD
Imatinib—Insomnia—Bupropion—obesity	5.43e-05	0.00048	CcSEcCtD
Imatinib—Haemoglobin—Topiramate—obesity	5.42e-05	0.000478	CcSEcCtD
Imatinib—Rhinitis—Topiramate—obesity	5.4e-05	0.000477	CcSEcCtD
Imatinib—Paraesthesia—Bupropion—obesity	5.4e-05	0.000477	CcSEcCtD
Imatinib—Haemorrhage—Topiramate—obesity	5.39e-05	0.000476	CcSEcCtD
Imatinib—Hepatitis—Topiramate—obesity	5.39e-05	0.000476	CcSEcCtD
Imatinib—Hypoaesthesia—Topiramate—obesity	5.36e-05	0.000474	CcSEcCtD
Imatinib—Dyspnoea—Bupropion—obesity	5.36e-05	0.000473	CcSEcCtD
Imatinib—Pharyngitis—Topiramate—obesity	5.35e-05	0.000472	CcSEcCtD
Imatinib—Somnolence—Bupropion—obesity	5.34e-05	0.000472	CcSEcCtD
Imatinib—Urinary tract disorder—Topiramate—obesity	5.32e-05	0.00047	CcSEcCtD
Imatinib—Oedema peripheral—Topiramate—obesity	5.31e-05	0.000469	CcSEcCtD
Imatinib—Connective tissue disorder—Topiramate—obesity	5.29e-05	0.000468	CcSEcCtD
Imatinib—Dyspepsia—Bupropion—obesity	5.29e-05	0.000467	CcSEcCtD
Imatinib—Urethral disorder—Topiramate—obesity	5.28e-05	0.000467	CcSEcCtD
Imatinib—Hypersensitivity—Orlistat—obesity	5.25e-05	0.000463	CcSEcCtD
Imatinib—Decreased appetite—Bupropion—obesity	5.22e-05	0.000461	CcSEcCtD
Imatinib—Gastrointestinal disorder—Bupropion—obesity	5.19e-05	0.000458	CcSEcCtD
Imatinib—Fatigue—Bupropion—obesity	5.18e-05	0.000458	CcSEcCtD
Imatinib—Constipation—Bupropion—obesity	5.14e-05	0.000454	CcSEcCtD
Imatinib—Pain—Bupropion—obesity	5.14e-05	0.000454	CcSEcCtD
Imatinib—Asthenia—Orlistat—obesity	5.11e-05	0.000451	CcSEcCtD
Imatinib—Erythema multiforme—Topiramate—obesity	5.09e-05	0.00045	CcSEcCtD
Imatinib—Hypersensitivity—Sibutramine—obesity	5.08e-05	0.000449	CcSEcCtD
Imatinib—Pruritus—Orlistat—obesity	5.04e-05	0.000445	CcSEcCtD
Imatinib—Eye disorder—Topiramate—obesity	5.04e-05	0.000445	CcSEcCtD
Imatinib—Tinnitus—Topiramate—obesity	5.02e-05	0.000444	CcSEcCtD
Imatinib—Cardiac disorder—Topiramate—obesity	5e-05	0.000442	CcSEcCtD
Imatinib—Flushing—Topiramate—obesity	5e-05	0.000442	CcSEcCtD
Imatinib—Feeling abnormal—Bupropion—obesity	4.95e-05	0.000437	CcSEcCtD
Imatinib—Asthenia—Sibutramine—obesity	4.95e-05	0.000437	CcSEcCtD
Imatinib—Gastrointestinal pain—Bupropion—obesity	4.91e-05	0.000434	CcSEcCtD
Imatinib—Angiopathy—Topiramate—obesity	4.89e-05	0.000432	CcSEcCtD
Imatinib—ABCB1—endocrine gland—obesity	4.88e-05	0.000944	CbGeAlD
Imatinib—Pruritus—Sibutramine—obesity	4.88e-05	0.000431	CcSEcCtD
Imatinib—Diarrhoea—Orlistat—obesity	4.87e-05	0.00043	CcSEcCtD
Imatinib—Immune system disorder—Topiramate—obesity	4.87e-05	0.00043	CcSEcCtD
Imatinib—Mediastinal disorder—Topiramate—obesity	4.86e-05	0.000429	CcSEcCtD
Imatinib—Chills—Topiramate—obesity	4.83e-05	0.000427	CcSEcCtD
Imatinib—Urticaria—Bupropion—obesity	4.77e-05	0.000422	CcSEcCtD
Imatinib—Alopecia—Topiramate—obesity	4.76e-05	0.000421	CcSEcCtD
Imatinib—Abdominal pain—Bupropion—obesity	4.75e-05	0.00042	CcSEcCtD
Imatinib—Body temperature increased—Bupropion—obesity	4.75e-05	0.00042	CcSEcCtD
Imatinib—Mental disorder—Topiramate—obesity	4.72e-05	0.000417	CcSEcCtD
Imatinib—Diarrhoea—Sibutramine—obesity	4.72e-05	0.000417	CcSEcCtD
Imatinib—Dizziness—Orlistat—obesity	4.71e-05	0.000416	CcSEcCtD
Imatinib—Erythema—Topiramate—obesity	4.69e-05	0.000414	CcSEcCtD
Imatinib—Malnutrition—Topiramate—obesity	4.69e-05	0.000414	CcSEcCtD
Imatinib—Flatulence—Topiramate—obesity	4.62e-05	0.000408	CcSEcCtD
Imatinib—Dysgeusia—Topiramate—obesity	4.59e-05	0.000406	CcSEcCtD
Imatinib—Dizziness—Sibutramine—obesity	4.56e-05	0.000403	CcSEcCtD
Imatinib—Back pain—Topiramate—obesity	4.54e-05	0.000401	CcSEcCtD
Imatinib—Vomiting—Orlistat—obesity	4.53e-05	0.0004	CcSEcCtD
Imatinib—Muscle spasms—Topiramate—obesity	4.51e-05	0.000398	CcSEcCtD
Imatinib—Rash—Orlistat—obesity	4.49e-05	0.000397	CcSEcCtD
Imatinib—Dermatitis—Orlistat—obesity	4.49e-05	0.000396	CcSEcCtD
Imatinib—Headache—Orlistat—obesity	4.46e-05	0.000394	CcSEcCtD
Imatinib—Hypersensitivity—Bupropion—obesity	4.43e-05	0.000391	CcSEcCtD
Imatinib—Vision blurred—Topiramate—obesity	4.42e-05	0.00039	CcSEcCtD
Imatinib—ABCB1—liver—obesity	4.4e-05	0.000851	CbGeAlD
Imatinib—Tremor—Topiramate—obesity	4.39e-05	0.000388	CcSEcCtD
Imatinib—Vomiting—Sibutramine—obesity	4.38e-05	0.000387	CcSEcCtD
Imatinib—Ill-defined disorder—Topiramate—obesity	4.35e-05	0.000384	CcSEcCtD
Imatinib—Rash—Sibutramine—obesity	4.35e-05	0.000384	CcSEcCtD
Imatinib—Dermatitis—Sibutramine—obesity	4.34e-05	0.000383	CcSEcCtD
Imatinib—Anaemia—Topiramate—obesity	4.34e-05	0.000383	CcSEcCtD
Imatinib—Headache—Sibutramine—obesity	4.32e-05	0.000381	CcSEcCtD
Imatinib—Asthenia—Bupropion—obesity	4.31e-05	0.000381	CcSEcCtD
Imatinib—Pruritus—Bupropion—obesity	4.25e-05	0.000375	CcSEcCtD
Imatinib—Nausea—Orlistat—obesity	4.23e-05	0.000374	CcSEcCtD
Imatinib—Malaise—Topiramate—obesity	4.23e-05	0.000374	CcSEcCtD
Imatinib—Vertigo—Topiramate—obesity	4.21e-05	0.000372	CcSEcCtD
Imatinib—Syncope—Topiramate—obesity	4.21e-05	0.000372	CcSEcCtD
Imatinib—Leukopenia—Topiramate—obesity	4.2e-05	0.000371	CcSEcCtD
Imatinib—Palpitations—Topiramate—obesity	4.15e-05	0.000366	CcSEcCtD
Imatinib—Loss of consciousness—Topiramate—obesity	4.12e-05	0.000364	CcSEcCtD
Imatinib—Diarrhoea—Bupropion—obesity	4.11e-05	0.000363	CcSEcCtD
Imatinib—Nausea—Sibutramine—obesity	4.09e-05	0.000362	CcSEcCtD
Imatinib—Cough—Topiramate—obesity	4.09e-05	0.000362	CcSEcCtD
Imatinib—Convulsion—Topiramate—obesity	4.06e-05	0.000359	CcSEcCtD
Imatinib—Hypertension—Topiramate—obesity	4.05e-05	0.000358	CcSEcCtD
Imatinib—Myalgia—Topiramate—obesity	3.99e-05	0.000353	CcSEcCtD
Imatinib—Arthralgia—Topiramate—obesity	3.99e-05	0.000353	CcSEcCtD
Imatinib—Chest pain—Topiramate—obesity	3.99e-05	0.000353	CcSEcCtD
Imatinib—Anxiety—Topiramate—obesity	3.98e-05	0.000352	CcSEcCtD
Imatinib—Dizziness—Bupropion—obesity	3.97e-05	0.000351	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	3.97e-05	0.00035	CcSEcCtD
Imatinib—Discomfort—Topiramate—obesity	3.95e-05	0.000348	CcSEcCtD
Imatinib—Dry mouth—Topiramate—obesity	3.91e-05	0.000345	CcSEcCtD
Imatinib—Confusional state—Topiramate—obesity	3.86e-05	0.000341	CcSEcCtD
Imatinib—Oedema—Topiramate—obesity	3.83e-05	0.000338	CcSEcCtD
Imatinib—Vomiting—Bupropion—obesity	3.82e-05	0.000337	CcSEcCtD
Imatinib—Infection—Topiramate—obesity	3.8e-05	0.000336	CcSEcCtD
Imatinib—Rash—Bupropion—obesity	3.79e-05	0.000335	CcSEcCtD
Imatinib—Dermatitis—Bupropion—obesity	3.79e-05	0.000334	CcSEcCtD
Imatinib—Shock—Topiramate—obesity	3.77e-05	0.000333	CcSEcCtD
Imatinib—Headache—Bupropion—obesity	3.76e-05	0.000332	CcSEcCtD
Imatinib—Nervous system disorder—Topiramate—obesity	3.75e-05	0.000332	CcSEcCtD
Imatinib—Thrombocytopenia—Topiramate—obesity	3.75e-05	0.000331	CcSEcCtD
Imatinib—Tachycardia—Topiramate—obesity	3.74e-05	0.00033	CcSEcCtD
Imatinib—Skin disorder—Topiramate—obesity	3.72e-05	0.000328	CcSEcCtD
Imatinib—Hyperhidrosis—Topiramate—obesity	3.7e-05	0.000327	CcSEcCtD
Imatinib—Anorexia—Topiramate—obesity	3.65e-05	0.000322	CcSEcCtD
Imatinib—Hypotension—Topiramate—obesity	3.58e-05	0.000316	CcSEcCtD
Imatinib—Nausea—Bupropion—obesity	3.57e-05	0.000315	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Topiramate—obesity	3.49e-05	0.000308	CcSEcCtD
Imatinib—Insomnia—Topiramate—obesity	3.46e-05	0.000306	CcSEcCtD
Imatinib—Paraesthesia—Topiramate—obesity	3.44e-05	0.000304	CcSEcCtD
Imatinib—Dyspnoea—Topiramate—obesity	3.41e-05	0.000301	CcSEcCtD
Imatinib—Somnolence—Topiramate—obesity	3.4e-05	0.000301	CcSEcCtD
Imatinib—Dyspepsia—Topiramate—obesity	3.37e-05	0.000298	CcSEcCtD
Imatinib—Decreased appetite—Topiramate—obesity	3.33e-05	0.000294	CcSEcCtD
Imatinib—Gastrointestinal disorder—Topiramate—obesity	3.3e-05	0.000292	CcSEcCtD
Imatinib—Fatigue—Topiramate—obesity	3.3e-05	0.000292	CcSEcCtD
Imatinib—Pain—Topiramate—obesity	3.27e-05	0.000289	CcSEcCtD
Imatinib—Constipation—Topiramate—obesity	3.27e-05	0.000289	CcSEcCtD
Imatinib—Feeling abnormal—Topiramate—obesity	3.15e-05	0.000279	CcSEcCtD
Imatinib—Gastrointestinal pain—Topiramate—obesity	3.13e-05	0.000276	CcSEcCtD
Imatinib—Urticaria—Topiramate—obesity	3.04e-05	0.000269	CcSEcCtD
Imatinib—Abdominal pain—Topiramate—obesity	3.03e-05	0.000267	CcSEcCtD
Imatinib—Body temperature increased—Topiramate—obesity	3.03e-05	0.000267	CcSEcCtD
Imatinib—Hypersensitivity—Topiramate—obesity	2.82e-05	0.000249	CcSEcCtD
Imatinib—Asthenia—Topiramate—obesity	2.75e-05	0.000243	CcSEcCtD
Imatinib—Pruritus—Topiramate—obesity	2.71e-05	0.000239	CcSEcCtD
Imatinib—Diarrhoea—Topiramate—obesity	2.62e-05	0.000231	CcSEcCtD
Imatinib—Dizziness—Topiramate—obesity	2.53e-05	0.000224	CcSEcCtD
Imatinib—Vomiting—Topiramate—obesity	2.43e-05	0.000215	CcSEcCtD
Imatinib—Rash—Topiramate—obesity	2.41e-05	0.000213	CcSEcCtD
Imatinib—Dermatitis—Topiramate—obesity	2.41e-05	0.000213	CcSEcCtD
Imatinib—Headache—Topiramate—obesity	2.4e-05	0.000212	CcSEcCtD
Imatinib—Nausea—Topiramate—obesity	2.27e-05	0.000201	CcSEcCtD
Imatinib—PDGFRA—Signaling Pathways—STAT3—obesity	8.22e-07	8.35e-06	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PIK3CB—obesity	8.22e-07	8.35e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—APOB—obesity	8.2e-07	8.33e-06	CbGpPWpGaD
Imatinib—PDGFRA—Disease—IL6—obesity	8.2e-07	8.33e-06	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—AKT1—obesity	8.2e-07	8.32e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GGT1—obesity	8.19e-07	8.32e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GOT1—obesity	8.19e-07	8.32e-06	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PTGS2—obesity	8.15e-07	8.27e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—APOB—obesity	8.13e-07	8.26e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—AGT—obesity	8.12e-07	8.24e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GPX1—obesity	8.11e-07	8.24e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MAPK8—obesity	8.1e-07	8.23e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CETP—obesity	8.1e-07	8.22e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CD36—obesity	8.09e-07	8.22e-06	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—MYC—obesity	8.07e-07	8.2e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—NCOA1—obesity	8.07e-07	8.19e-06	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TGFB1—obesity	8.05e-07	8.18e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PPARG—obesity	8.04e-07	8.17e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SDC1—obesity	8.01e-07	8.13e-06	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL6—obesity	8e-07	8.13e-06	CbGpPWpGaD
Imatinib—KIT—Disease—AKT1—obesity	7.99e-07	8.12e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—APOE—obesity	7.95e-07	8.08e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—STK11—obesity	7.95e-07	8.07e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CYP19A1—obesity	7.95e-07	8.07e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—POMC—obesity	7.93e-07	8.06e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CD36—obesity	7.9e-07	8.02e-06	CbGpPWpGaD
Imatinib—LCK—Disease—MYC—obesity	7.89e-07	8.01e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—INS—obesity	7.89e-07	8.01e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—CAV1—obesity	7.88e-07	8e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—AKR1C3—obesity	7.88e-07	8e-06	CbGpPWpGaD
Imatinib—LCK—Disease—TGFB1—obesity	7.87e-07	7.99e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—APOA1—obesity	7.86e-07	7.98e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—LPL—obesity	7.83e-07	7.96e-06	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL6—obesity	7.8e-07	7.92e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—LPL—obesity	7.77e-07	7.89e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SCARB1—obesity	7.75e-07	7.87e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PIK3CB—obesity	7.69e-07	7.81e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MTOR—obesity	7.69e-07	7.81e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MTHFR—obesity	7.67e-07	7.79e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GPX1—obesity	7.64e-07	7.76e-06	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—MYC—obesity	7.64e-07	7.76e-06	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—AKT1—obesity	7.64e-07	7.76e-06	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TGFB1—obesity	7.62e-07	7.74e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GPX1—obesity	7.58e-07	7.69e-06	CbGpPWpGaD
Imatinib—PDGFRA—Disease—AKT1—obesity	7.57e-07	7.68e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	7.53e-07	7.64e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SREBF1—obesity	7.53e-07	7.64e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PPARA—obesity	7.52e-07	7.64e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MTHFR—obesity	7.48e-07	7.6e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CD36—obesity	7.44e-07	7.56e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—STAT3—obesity	7.41e-07	7.52e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—COMT—obesity	7.39e-07	7.51e-06	CbGpPWpGaD
Imatinib—PDGFRB—Disease—IL6—obesity	7.39e-07	7.5e-06	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—AKT1—obesity	7.38e-07	7.5e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CD36—obesity	7.38e-07	7.49e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PPARA—obesity	7.34e-07	7.46e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PIK3CD—obesity	7.33e-07	7.44e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GOT2—obesity	7.32e-07	7.44e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PPARGC1A—obesity	7.29e-07	7.4e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GNB3—obesity	7.29e-07	7.4e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—AGT—obesity	7.29e-07	7.4e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—HMOX1—obesity	7.26e-07	7.37e-06	CbGpPWpGaD
Imatinib—LCK—Immune System—PIK3CA—obesity	7.25e-07	7.37e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ALB—obesity	7.23e-07	7.34e-06	CbGpPWpGaD
Imatinib—ABL1—Immune System—AKT1—obesity	7.2e-07	7.31e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—PIK3CG—obesity	7.18e-07	7.29e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—FASN—obesity	7.17e-07	7.28e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—APOE—obesity	7.14e-07	7.25e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—BCHE—obesity	7.14e-07	7.25e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—AGT—obesity	7.11e-07	7.22e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GNAS—obesity	7.1e-07	7.21e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CAV1—obesity	7.07e-07	7.18e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—APOA1—obesity	7.06e-07	7.17e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MTHFR—obesity	7.05e-07	7.16e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MTHFR—obesity	6.99e-07	7.1e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—APOE—obesity	6.97e-07	7.08e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—APOB—obesity	6.95e-07	7.06e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—PPARG—obesity	6.93e-07	7.03e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PPARA—obesity	6.92e-07	7.03e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—NOS3—obesity	6.92e-07	7.03e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PIK3R1—obesity	6.92e-07	7.03e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CAV1—obesity	6.9e-07	7.01e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—APOA1—obesity	6.89e-07	7e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CYP2E1—obesity	6.88e-07	6.99e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MYC—obesity	6.88e-07	6.99e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TGFB1—obesity	6.87e-07	6.97e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PPARA—obesity	6.86e-07	6.97e-06	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—PIK3CA—obesity	6.85e-07	6.96e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—POMC—obesity	6.83e-07	6.94e-06	CbGpPWpGaD
Imatinib—PDGFRB—Disease—AKT1—obesity	6.82e-07	6.92e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NQO1—obesity	6.81e-07	6.91e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—INS—obesity	6.79e-07	6.9e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—obesity	6.76e-07	6.86e-06	CbGpPWpGaD
Imatinib—ALB—Hemostasis—AKT1—obesity	6.75e-07	6.86e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—AGT—obesity	6.7e-07	6.81e-06	CbGpPWpGaD
Imatinib—LCK—Disease—PIK3CA—obesity	6.7e-07	6.8e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MMP9—obesity	6.69e-07	6.79e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—AGT—obesity	6.64e-07	6.75e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—LPL—obesity	6.64e-07	6.74e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—APOE—obesity	6.57e-07	6.67e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GCG—obesity	6.53e-07	6.63e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—SLC2A4—obesity	6.53e-07	6.63e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—APOE—obesity	6.51e-07	6.61e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CAV1—obesity	6.51e-07	6.61e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MAPK8—obesity	6.5e-07	6.6e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—APOA1—obesity	6.49e-07	6.59e-06	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—PIK3CA—obesity	6.49e-07	6.59e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GPX1—obesity	6.47e-07	6.57e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CAV1—obesity	6.45e-07	6.55e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PIK3CG—obesity	6.44e-07	6.54e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CYCS—obesity	6.44e-07	6.54e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—APOA1—obesity	6.43e-07	6.53e-06	CbGpPWpGaD
Imatinib—LCK—Immune System—IL6—obesity	6.42e-07	6.52e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PIK3CB—obesity	6.39e-07	6.48e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PTGS2—obesity	6.33e-07	6.43e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GOT1—obesity	6.32e-07	6.42e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GGT1—obesity	6.32e-07	6.42e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—PIK3CD—obesity	6.31e-07	6.41e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CD36—obesity	6.31e-07	6.4e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PIK3CG—obesity	6.29e-07	6.39e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NCOA1—obesity	6.23e-07	6.32e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PPARG—obesity	6.22e-07	6.31e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	6.16e-07	6.26e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CYP19A1—obesity	6.14e-07	6.23e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—STK11—obesity	6.14e-07	6.23e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—POMC—obesity	6.13e-07	6.23e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—INS—obesity	6.1e-07	6.19e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PPARG—obesity	6.07e-07	6.16e-06	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL6—obesity	6.07e-07	6.16e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—POMC—obesity	5.99e-07	6.08e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MTHFR—obesity	5.97e-07	6.07e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—PIK3R1—obesity	5.96e-07	6.05e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—NOS3—obesity	5.96e-07	6.05e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—INS—obesity	5.95e-07	6.05e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—STAT3—obesity	5.95e-07	6.04e-06	CbGpPWpGaD
Imatinib—LCK—Disease—IL6—obesity	5.93e-07	6.02e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PIK3CG—obesity	5.93e-07	6.02e-06	CbGpPWpGaD
Imatinib—LCK—Immune System—AKT1—obesity	5.93e-07	6.02e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PIK3CG—obesity	5.87e-07	5.97e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PPARA—obesity	5.86e-07	5.95e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—PIK3CA—obesity	5.84e-07	5.93e-06	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL6—obesity	5.74e-07	5.83e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PPARG—obesity	5.72e-07	5.81e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—COMT—obesity	5.7e-07	5.79e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—AGT—obesity	5.68e-07	5.77e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PPARG—obesity	5.67e-07	5.76e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PIK3CD—obesity	5.66e-07	5.75e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—POMC—obesity	5.64e-07	5.73e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PPARGC1A—obesity	5.63e-07	5.71e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GNB3—obesity	5.63e-07	5.71e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—INS—obesity	5.61e-07	5.7e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—HMOX1—obesity	5.6e-07	5.69e-06	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—AKT1—obesity	5.6e-07	5.68e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—POMC—obesity	5.59e-07	5.68e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ALB—obesity	5.59e-07	5.68e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—APOE—obesity	5.56e-07	5.65e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—INS—obesity	5.56e-07	5.65e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PIK3CD—obesity	5.53e-07	5.61e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MYC—obesity	5.52e-07	5.61e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CAV1—obesity	5.51e-07	5.6e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TGFB1—obesity	5.51e-07	5.6e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—PIK3CB—obesity	5.5e-07	5.58e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—APOA1—obesity	5.5e-07	5.58e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GNAS—obesity	5.48e-07	5.56e-06	CbGpPWpGaD
Imatinib—LCK—Disease—AKT1—obesity	5.47e-07	5.56e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ALB—obesity	5.46e-07	5.54e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—PTGS2—obesity	5.45e-07	5.53e-06	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PIK3CA—obesity	5.43e-07	5.52e-06	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PIK3CA—obesity	5.39e-07	5.47e-06	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PIK3CA—obesity	5.38e-07	5.46e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOB—obesity	5.36e-07	5.45e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PIK3R1—obesity	5.35e-07	5.43e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—NOS3—obesity	5.35e-07	5.43e-06	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—AKT1—obesity	5.3e-07	5.38e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—obesity	5.27e-07	5.35e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PIK3R1—obesity	5.22e-07	5.3e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—NOS3—obesity	5.22e-07	5.3e-06	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PIK3CA—obesity	5.22e-07	5.3e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PIK3CD—obesity	5.21e-07	5.29e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL6—obesity	5.17e-07	5.25e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PIK3CD—obesity	5.16e-07	5.24e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ALB—obesity	5.14e-07	5.22e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—LPL—obesity	5.12e-07	5.2e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ALB—obesity	5.1e-07	5.18e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PIK3CG—obesity	5.02e-07	5.1e-06	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PIK3CA—obesity	5.01e-07	5.09e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GPX1—obesity	5e-07	5.07e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PIK3CB—obesity	4.94e-07	5.01e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—NOS3—obesity	4.92e-07	5e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PIK3R1—obesity	4.92e-07	5e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PTGS2—obesity	4.89e-07	4.97e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PIK3R1—obesity	4.88e-07	4.95e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—NOS3—obesity	4.88e-07	4.95e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CD36—obesity	4.87e-07	4.94e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PPARG—obesity	4.85e-07	4.92e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PIK3CB—obesity	4.82e-07	4.89e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—POMC—obesity	4.78e-07	4.85e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PTGS2—obesity	4.77e-07	4.85e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—AKT1—obesity	4.77e-07	4.85e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—INS—obesity	4.75e-07	4.83e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PIK3CA—obesity	4.69e-07	4.76e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MTHFR—obesity	4.61e-07	4.68e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PIK3CB—obesity	4.54e-07	4.61e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PPARA—obesity	4.52e-07	4.59e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PIK3CB—obesity	4.5e-07	4.57e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PTGS2—obesity	4.5e-07	4.57e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PTGS2—obesity	4.46e-07	4.53e-06	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—AKT1—obesity	4.44e-07	4.51e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PIK3CD—obesity	4.41e-07	4.48e-06	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—AKT1—obesity	4.4e-07	4.47e-06	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—AKT1—obesity	4.39e-07	4.46e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—AGT—obesity	4.38e-07	4.45e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ALB—obesity	4.36e-07	4.42e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOE—obesity	4.29e-07	4.36e-06	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—AKT1—obesity	4.26e-07	4.33e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CAV1—obesity	4.25e-07	4.32e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—APOA1—obesity	4.24e-07	4.31e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PIK3R1—obesity	4.17e-07	4.23e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—NOS3—obesity	4.17e-07	4.23e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL6—obesity	4.15e-07	4.22e-06	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—AKT1—obesity	4.09e-07	4.16e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PIK3CA—obesity	3.89e-07	3.95e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PIK3CG—obesity	3.87e-07	3.93e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PIK3CB—obesity	3.85e-07	3.91e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—AKT1—obesity	3.83e-07	3.89e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PTGS2—obesity	3.81e-07	3.87e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PPARG—obesity	3.74e-07	3.8e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—POMC—obesity	3.69e-07	3.75e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—INS—obesity	3.67e-07	3.72e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PIK3CD—obesity	3.41e-07	3.46e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ALB—obesity	3.36e-07	3.41e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—PIK3CA—obesity	3.35e-07	3.4e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PIK3R1—obesity	3.22e-07	3.27e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NOS3—obesity	3.22e-07	3.27e-06	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—AKT1—obesity	3.18e-07	3.23e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PIK3CA—obesity	3.01e-07	3.06e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PIK3CB—obesity	2.97e-07	3.01e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PTGS2—obesity	2.94e-07	2.99e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PIK3CA—obesity	2.94e-07	2.98e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PIK3CA—obesity	2.77e-07	2.81e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PIK3CA—obesity	2.74e-07	2.79e-06	CbGpPWpGaD
Imatinib—ALB—Metabolism—AKT1—obesity	2.74e-07	2.78e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—AKT1—obesity	2.46e-07	2.5e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—AKT1—obesity	2.4e-07	2.44e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PIK3CA—obesity	2.34e-07	2.38e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—AKT1—obesity	2.26e-07	2.3e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—AKT1—obesity	2.24e-07	2.28e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—AKT1—obesity	1.92e-07	1.95e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PIK3CA—obesity	1.81e-07	1.84e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—AKT1—obesity	1.48e-07	1.5e-06	CbGpPWpGaD
